$561.00
Catalog Number: CT1002b
This assay employs a quantitative chromogenic activity technique that measures the specified antigen in samples.
Product Size:96 Well Plate
| Format | Chromogenic Activity Assay |
|---|---|
| Entrez Gene | 2152 |
| Range | 7.81-2.pdf50 pM |
| Samples Type | Cell Lysates, Plasma, Serum, Tissue Extract, Urine |
| Associated Disease | Cancer |
| Species | Human |
| UniProt | P13726 |
| Storage | Refer to component labels for details |
| Application | Assay |
| Plex | 1 |
| Usage | For Research Use Only, Not To Be Used For Diagnostic Purposes |
Lipo)
* Su Y et al. (2024) EML4-ALK fusion protein in Lung cancer cells enhances venous thrombogenicity through the pERK1/2-AP-1-tissue factor axis. J Thromb Thrombolysis. 57(1):67-81.
* Shibata C et al. (2024) CA19-9-Positive Extracellular Vesicle Is a Risk Factor for Cancer-Associated Thrombosis in Pancreatic Cancer. Gastro Hep Adv. 2024 Feb 29;3(4):551-561.
* Krishnamachary B et al. (2021) Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity. J Extracell Vesicles. 10(9):e12117.
* Hartono F et al. (2021) Trauma magnitude of the meta-epyphyseal cancellous affects the incidence of deep vein thrombosis. A prospective cohort study on the dynamic of Collagen I, Collagen IV, Tissue factor, P-Selectin and Nitric Oxide in the thrombus formation following hip and knee surgeries. Ann Med Surg (Lond). 63:102190.
* Marchini J et al. (2020) Oxidized Low-Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles. J Am Heart Assoc. 9(15):e015878.
* Khawaja AA et al. (2020) HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet Crosstalk. Circ Res. 127(11):1365-1380.
* Hsu CC et al. (2020) High-intensity interval training recuperates capacity of endogenous thrombin generation in heart failure patients with reduced ejection fraction. Thromb Res. 187:159-165.
* Yang X et al. (2019) Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure. Immunity. 51(6):983-996
* Kasuda S et al. (2019) Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor. Int Arch Allergy Immunol. 179(2):158-164.
* Siennicka A et al. (2018) Homocysteine-Enhanced Proteolytic and Fibrinolytic Processes in Thin Intraluminal Thrombus and Adjacent Wall of Abdominal Aortic Aneurysm: Study In Vitro. Biomed Res Int. 2018: 3205324.
* Siennicka A et al. (2018) Tissue factor levels and the fibrinolytic system in thin and thick intraluminal thrombus and underlying walls of abdominal aortic aneurysms. Journal of Vascular Surgery.
* Kasuda S et al. (2018) Experimental hypercoagulable state induced by tissue factor expression in monocyte-derived dendritic cells and its modulation by C1 inhibitor. J Thromb Thrombolysis. 46(2):219-226.
* Nakata M et al. (2017) Relevance of hemolysis-induced tissue factor expression on monocytes in soft clot formation in alcohol-containing blood. Leg Med (Tokyo). 25:83-88
* Pericleous C et al. (2015) Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of beta2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis. Rheumatology (Oxford). 54(4):722-7.
* Wang T et al. (2014) Epigallocatechin-3-gallate inhibits TF and TNF-alpha expression induced by the anti-beta2GPI/beta2GPI complex in human THP-1 cells.Int J Mol Med. 33(4):994-1002.
* Supriyadi D (2014) Pengaruh simvastatin terhadap kadar tissue factor dan plasminogen activator inhibitor-1 pada pasien DM tipe 2. Sebelas Maret University. Thesis.
* Romay-Penabad Z et al. (2014) Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies. Lupus. 23(12):1324-6.
* Yeh HH et al. (2013) Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma. PLoS One. 8(9):e75287
* Sambola A et al. (2013) Prognostic impact of tissue factor pathway on long-term ischemic events of ST-elevated myocardial infarction treated with a primary percutaneous coronary intervention. Int J Cardiol. 168(3):2916-8.
* Chen C et al. (2013) EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One. 8(4):e60860.
* Zhou H et al. (2012) Activation of MAPKs in the anti-beta2GPI/beta2GPI-induced tissue factor expression through TLR4/IRAKs pathway in THP-1 cells.Thromb Res. 130(4):e229-35.
* Ye R et al. (2012) Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thromb. Res. 130(2):253-258.
* Sanchez-Solana B et al. (2012) p21-activated kinase-1 signaling regulates transcription of tissue factor and tissue factor pathway inhibitor. J Biol Chem. 287(47):39291-302.
* Zhou H et al. (2011) Toll-like receptor (TLR)-4 mediates anti-beta(2) GPI/Beta(2) GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol. 163(2):189-198
* Jiang WH et al. (2011) Regulatory role of RhoA/Rho kinase in the effect of fluvastatin on tumor necrosis factor-alpha induced expression of tissue factor. Afr. J. Pharm. Pharmacol. 5(12):1462-1466
* Wysoczynski M et al. (2010) Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Mol Cancer Res. 8(5):677-690
* Wysoczynski M et al. (2010) Thrombin regulates the metastatic potential of human rhabdomyosarcoma cells: distinct role of PAR1 and PAR3 signaling. Mol Cancer Res. 8(5):677-690
* White TA et al. (2010) Tissue factor pathway inhibitor overexpression inhibits hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol. 43:35-45
* White TA (2010) Murine strain differences in hemostasis and thrombosis and tissue factor pathway inhibitor. Thromb Res. 125(1):84-89
* Okuda M and Yoshida K (2008) Reagent for measuring clotting time and method for stabilizing tissue factor. European Application number: 08005295.4 and USPTO Patent Application number: 20080241941. Patent 7867771 Issued on January 11, 2011
* Zhang X et al. (2007) Plasma Thrombomodulin, Fibrinogen, and Activity of Tissue Factor as Risk Factors for Acute Cerebral Infarction. American Journal of Clinical Pathology 128(2):287-292
* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195
* Sakurai K et al. (2004) Role of p38 Mitogen-Activated Protein Kinase in Thrombus Formation. J Recept Signal Transduct Res. 24(4):283-296
Loading data...
